Navigation Links
Biochemical cascade causes bone marrow inflammation, leading to serious blood disorders
Date:7/3/2014

INDIANAPOLIS -- Like a line of falling dominos, a cascade of molecular events in the bone marrow produces high levels of inflammation that disrupt normal blood formation and lead to potentially deadly disorders including leukemia, an Indiana University-led research team has reported.

The discovery, published by the journal Cell Stem Cell, points the way to potential new strategies to treat the blood disorders and further illuminates the relationship between inflammation and cancer, said lead investigator Nadia Carlesso, M.D., Ph.D., associate professor of pediatrics at the Indiana University School of Medicine.

Bone marrow includes the cells that produce the body's red and white blood system cells in a process called hematopoiesis. The marrow also provides a support system and "home" for the blood-producing cells called the hematopoietic microenvironment. The new research demonstrates the importance of the hematopoietic microenvironment in the development of a group of potentially deadly diseases called myeloproliferative disorders.

"It has been known for years that there are links between inflammation and cancer, but these studies have been challenged by the lack of genetic models, especially for blood-based malignancies," said Dr. Carlesso, a member of the hematologic malignancy and stem cell biology program within the Wells Center of Pediatric Research at IU.

The researchers focused on what happens when there are abnormally low levels of a molecule called Notch, which plays an important role in the process of blood cell production. Using a genetically modified mouse, they found that the loss of Notch function in the microenvironment causes a chain of molecular events that result in excess production of inflammatory factors.

The high levels of inflammation in the bone marrow were associated with the development of a myeloproliferative disorder in the mice. Myeloproliferative diseases in humans can result in several illnesses caused by overproduction of myeloid cells, which are normally are used to fight infections. These diseases can put patients at risk for heart attack or stroke, and frequently progress into acute leukemia and bone marrow failure, which have fatal outcomes. Unfortunately, there are no effective therapies for the majority of myeloproliferative diseases.

When Dr. Carlesso's team blocked the activity of one of the molecules in this biochemical cascade, the myeloproliferative disorder in the mice was reversed. In addition, elevated levels of the blocked molecule were found in samples from human patients with myeloproliferative disease. These findings suggest that developing drugs that target this inflammatory reaction at different key points could be a promising strategy to limit the development of myeloproliferative disease in humans.

The molecular cascade leading to inflammation was not occurring directly in the bone marrow cells that produce blood cells, but in cells of the bone marrow microenvironment, especially in endothelial cells that line the capillaries -- tiny blood vessels -- inside the bone marrow. This was a key discovery, Dr. Carlesso said.

"This work indicates that we need to target not only the tumor cells, but also the inflammatory microenvironment that surrounds them and may contribute to their generation," she said.

"We believe that this combined strategy will be more effective in preventing myeloproliferative disease progression and transformation in acute leukemias."

Dr. Carlesso also noted that the Notch molecule is mostly known as an oncogene -- one that can cause cancer -- and so is often targeted by therapies for other types of cancer. The new research indicates that clinicians need to be aware of the effects that reducing levels of Notch function could have on the blood development process, she said.


'/>"/>

Contact: Eric Schoch
eschoch@iu.edu
316-274-8205
Indiana University
Source:Eurekalert  

Related medicine news :

1. Biological and Biochemical Product Manufacturing in China Industry Research Report – Now Available from IBISWorld
2. New study pinpoints biochemical mechanism underlying fibrosis following glaucoma surgery
3. Cascade Gasket Utilizes the NOVAtime 4000 SaaS Workforce Management System to Manage Business Processes in Real-Time
4. Campus Teamwear Donates Cheer Gear for Cascade AIDS Project Fundraiser
5. Hot Pot with chicken causes campylobacter infections in Switzerland
6. Causes of serious pain syndrome closer to discovery
7. Research proves shock wave from explosives causes significant eye damage
8. Healthy component of red wine, resveratrol, causes pancreatic abnormalities in fetuses
9. Water pipe smoking causes significant exposure to nicotine and cancer-causing agents
10. TB lung infection causes changes in the diversity of gut bacteria in mice
11. Long-term antibiotic treatment for Q fever causes weight gain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biochemical cascade causes bone marrow inflammation, leading to serious blood disorders
(Date:7/26/2017)... ... July 26, 2017 , ... Team Type 1 Foundation, a nonprofit ... everyone affected by diabetes, is excited to announce the 106 college athletes with type ... , Established in 2005, the Team Type 1 Foundation has bestowed a total of ...
(Date:7/26/2017)... Florida (PRWEB) , ... July 26, 2017 , ... ... for dogs and cats has opened in Jupiter. The state of the ... (cardiology) and class leading treatments with a goal of providing heart patients longer ...
(Date:7/26/2017)... ... 26, 2017 , ... Isodiol International Inc. (CSE: ISOL) (OTC: ... the development of pharmaceutical and consumer products, announces the operational numbers of its ... Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 based on revenues ...
(Date:7/26/2017)... ... July 26, 2017 , ... Wendy M. Musielak, a partner at the Andrew Cores ... County Bar Association’s third Vice President earlier this year. She will serve the membership in ... second Vice President, in accordance with the organization’s by-laws. , Musielak joined the ...
(Date:7/26/2017)... ... July 26, 2017 , ... The number of adults ... United States, but ways to improve asthma control in the population are not well ... Practice (JACI: In Practice), an official journal of the American Academy of Allergy, Asthma ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:7/1/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... call will be broadcast live over the Internet on Thursday, ... release detailing the quarterly results will be made available at ... The live audio webcast can be accessed via ... will be archived for replay following the conference call. ...
Breaking Medicine Technology: